Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver Disease

NCT03748511 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2023-03-06

No results posted yet for this study

Summary

This study investigates the relation between the gastrointestinal tract bacteria and the progression of fatty liver disease .

Conditions

  • Patients With Fatty Liver Disease

Interventions

OTHER

fibroscan and stool sample

patients undergo ultrasaound (fibroscan) in order to stage the liver disease.

Sponsors & Collaborators

  • HaEmek Medical Center, Israel

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-05
Primary Completion
2022-09-08
Completion
2022-09-08

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03748511 on ClinicalTrials.gov